[1]韩松梅,陈莉丽,李强,等.2型糖尿病患者不同HbA1c水平和骨代谢 指标的关系[J].国际内分泌代谢杂志,2017,37(05):293-297.
　Han Songmei*,Chen Lili,Li Qiang,et al.Relationship between different HbA1c levels and bone metabolic markers in type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2017,37(05):293-297.
点击复制

2型糖尿病患者不同HbA1c水平和骨代谢 指标的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年05期
页码:
293-297
栏目:
论著
出版日期:
2017-09-20

文章信息/Info

Title:
Relationship between different HbA1c levels and bone metabolic markers in type 2 diabetic patients
作者:
韩松梅; 陈莉丽; 李强; 张巾超; 唐菲菲
572000 三亚,解放军总医院海南分院内分泌科(韩松梅); 150000 哈尔滨医科大学附属第二医院内分泌一病区(陈莉丽,李强,张巾超,唐菲菲)
Author(s):
Han Songmei*;  Chen Lili;  Li Qiang;  Zhang Jinchao;  Tang Feifei.
*Department of Endocrinology, Hainan Branch of the PLA General Hospital, Sanya 572000, China
关键词:
2型糖尿病;  骨质疏松;  HbA1c;  骨γ-羧谷氨酸包含蛋白;  碱性磷酸酶;  Ⅰ型胶原交联羧基端肽
Keywords:
Type 2 diabetes mellitus;  Osteoporosis;  HbA1c;  Bone gamma-carboxyglutamic-acid-containing proteins;  Alkaline phosphatase;  Cross linked C-telopeptide of type Ⅰ collagen
文献标志码:
A
摘要:
目的 观察2型糖尿病患者不同HbA1c水平对骨代谢指标骨γ-羧谷氨酸包含蛋白(骨钙素)、Ⅰ型胶原交联羧基端肽(CTX-Ⅰ)、碱性磷酸酶(ALP)的影响。方法 选取2013年10月—2014年1月在哈尔滨医科大学附属第二医院内分泌科住院的120例男性2型糖尿病患者和来自体检中心的40名健康男性作为研究对象。将120例2型糖尿病患者根据HbA1c水平分为为HbA1c≤7%组、HbA1c 7%～9%组、HbA1c≥9%组,将40名健康男性作为对照组。采集其年龄、体重指数、病程及血钙、血磷、丙氨酸氨基转移酶、天门冬氨酸氨基转移酶等临床指标,检测血清HbA1c、骨钙素、CTX-Ⅰ、ALP等指标。对4组间HbA1c水平与骨钙素、CTX-Ⅰ、ALP进行相关性和回归分析。结果 与对照组相比,HbA1c≤7%组、HbA1c 7%～9%组及HbA1c≥9%组血清骨钙素水平显著降低(F=7.211,P<0.05),血清ALP、CTX-Ⅰ水平显著升高(F=4.382、809.475,P<0.05); 与HbA1c≤7%组相比,HbA1c7%～9%组和HbA1c≥9%组血清ALP水平显著降低(P<0.05),血清CTX-Ⅰ水平显著升高(P<0.05); 与HbA1c 7%～9%组相比,HbA1c≥9%组血清骨钙素水平显著降低(P<0.05),血清CTX-Ⅰ水平显著升高(P<0.05)。Spearman相关分析发现, 骨钙素与空腹血糖(r=-0.249,P=0.002)、糖化白蛋白(GA, r=-0.321,P=0.000)、HbA1c(r=-0.288,P=0.000)水平呈负相关, ALP、CTX-Ⅰ与空腹血糖(r=0.218、0.321)、GA(r=0.302、0.291)、HbA1c(r=0.321、0.238)水平呈正相关(P均<0.01)。进一步经线性回归分析发现,骨钙素水平与GA(β=-0.086,P=0.008)、HbA1c(β=-0.502,P=0.001)呈负相关,CTX-Ⅰ水平与空腹血糖(β=0.042,P=0.003)、GA(β=0.007,P=0.015)、HbA1c(β=0.037,P=0.009)呈正相关。结论 2型糖尿病患者存在骨代谢指标异常,且HbA1c与骨钙素、CTX-Ⅰ水平相关。
Abstract:
Objective To study the effects of different HbA1c levels on bone γ-carboxyglutamic-acid-containing protein(BGP), cross linked C-telopeptide of type Ⅰ collagen(CTX-Ⅰ), alkaline phosphatase(ALP)in type 2 diabetic patients.Methods A total of 120 male patients with type 2 diabetes mellitus(T2DM)newly admitted to the Department of Endocrinology, the Second Affiliated Hospital of Haerbin Medical Collage from October 2013 to January 2014 and 40 male healthy subjects from the physical examination center were included. Patients with T2DM were divided into HbA1c≤7% group, HbA1c 7%-9% group and HbA1c≥9% group according to their HbA1c levels, and 40 male healthy subjects were served as control group. Data of age, body mass index(BMI), course of disease and serum calcium, phosphorus, alanine aminotransferase, aspartate aminotransferase levels were acquired and serum HbA1c, BGP, CTX-Ⅰ, ALP levels were detected. Correlation and regression analysis were used to investigate the correlation between HbA1c and BGP, CTX-Ⅰ, ALP.Results Compared with control group, serum BGP levels in HbA1c≤7% group, HbA1c 7%-9% group and HbA1c≥9% group were significantly decreased(F=7.211, P<0.05), while serum ALP, CTX-Ⅰ levels were significantly increased(F=4.382, 809.475, all P<0.05). Compared with HbA1c≤7% group, ALP levels in HbA1c 7%-9% group and HbA1c≥9% group were significantly decreased(P<0.05), whereas serum CTX-Ⅰ levels were significantly increased(P<0.05). Compared with HbA1c 7%-9% group, serum BGP level in HbA1c≥9% group was significantly decreased(P<0.05), while serum CTX-Ⅰ level was significantly increased(P<0.05). Spearman analysis revealed that BGP level was negatively correlated with fasting blood glucose(FBG, r=-0.249, P=0.002), glycated albumin(GA, r=-0.321, P=0.000), HbA1c(r=-0.288, P=0.000), whereas ALP, CTX-Ⅰ level were positively correlated with FBG(r=0.218, 0.321), GA(r=0.302, 0.291)and HbA1c(r=0.321, 0.238), all P<0.01. Further regression analysis revealed that BGP level was negatively correlated with GA(β=-0.086, P=0.008), HbA1c(β=-0.502, P=0.001), while CTX-Ⅰ level was positively correlated with FBG(β=0.042, P=0.003), GA(β=0.007, P=0.015)and HbA1c(β=0.037, P=0.009).Conclusion Bone metabolic parameters are abnormal in type 2 diabetic patients, and BGP, CTX-Ⅰ levels are correlated with HbA1c.

参考文献/References:

[1] Christensen TM, Bülow J, Simonsen L, et al. Bone mineral density in diabetes mellitus patients with and without a Charcot foot[J].Clin Physiol Funct Imaging, 2010,30(2):130-134. DOI:10.1111/j.1475-097X.2009.00915.x.
[2] Yamamoto M. Secondary osteoporosis or secondary contributors to bone loss in fracture. Bone metabolic disorders in patients with diabetes mellitus[J].Clin Calcium,2013,23(9):1327-1335. DOI:CliCa130913271335.
[3] Catalano A, Morabito N, Di Vieste G,et al. Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with type 1 diabetes mellitus[J].J Endocrinol Invest, 2013,36(5):347-251. DOI:10.3275/8646.
[4] de Almeida Pereira Coutinho M, Bandeira E, de Almeida JM,et al. Low bone mass is associated with increased carotid intima media thickness in men with type 2 diabetes mellitus[J].Clin Med Insights Endocrinol Diabetes,2013,6:1-6. DOI:10.4137/CMED.S11843.
[5] Oei L, Zillikens MC, Dehghan A, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study[J].Diabetes Care,2013,36(6):1619-1628. DOI:10.2337/dc12-1188.
[6] Zhang M, Li Y, Ma Q,et al. Relevance of parathyroid hormone(PTH), vitamin 25(OH)D3, calcitonin(CT), bone metabolic markers, and bone mass density(BMD)in 860 female cases[J].Clin Exp Obstet Gynecol,2015,42(2):129-32.
[7] Takeuchi Y. Diabetes mellitus and osteoporosis. Therapeutic strategy for osteoporosis in patients with diabetes mellitus[J].Clin Calcium,2012,22(9):1410-1415.DOI:CliCa120914101415.
[8] Molor-Erdene P, Okajima K, Isobe H,et al. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression[J].Am J Physiol Heart Circ Physiol,2005,288(3):H1265-H1271.DOI: 10.1152/ajpheart.00885.2004.
[9] Isaia G, Bodrato L, Carlevatto V,et al. Osteoporosis in type Ⅱ diabetes[J].Acta Diabetol Lat,1987,24(4):305-310.
[10] Kurra S, Fink DA, Siris ES. Osteoporosis-associated fracture and diabetes[J].Endocrinol Metab Clin North Am,2014,43(1):233-243. DOI:10.1016/j.ecl.2013.09.004.
[11] 刘婷, 张丰正, 王鸿度. 糖尿病中胰岛素与骨钙素的交互作用[J].中国医学创新,2015,12(36):140-143.DOI:10.3969/j.issn.1674-4985.2015.36.046.
[12] 李刚,黄国福.前列腺癌患者骨代谢标志物的临床应用[J]. 临床医学,2010, 8(1): 2044-2045.DOI:10.3969/j.issn.1006-1959.2010.08.065.
[13] Ueda M, Inaba M, Okuno S,et al. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH[J].Life Sci,2005,77(10):1130-1139.DOI:10.1016/j.lfs.2005.02.007.
[14] 陈邹阳. 联合检测骨折患者血浆碱性磷酸酶与纤维蛋白原的意义[J]. 国际检验医学杂志, 2012,33(23): 2922-2923.DOI:10.3969/j.issn.1673-4130.2012.23.053.
[15] Herrmann M, Seibel MJ. The amino- and carboxyterminal cross-linked telopeptides of collagen type Ⅰ, NTX-Ⅰ and CTX-Ⅰ: a comparative review[J].Clin Chim Acta,2008,393(2):57-75. DOI:10.1016/j.cca.2008.03.020.
[16] 皇甫建, 李彩萍, 王娟, 等. 2型糖尿病患者骨质疏松发生率及骨代谢生化指标测定分析[J]. 中国骨质疏松杂志,2011,17(4):300-303.DOI:1006-7108(2011)04-0300-04.
[17] Lumachi F, Orlando R, Fallo F, et al. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type Ⅰ collagen and bone mineral density in elderly men. Preliminary results[J].In Vivo,2012,26(6):1041-1044.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(05):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(05):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(05):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(05):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(05):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]

备注/Memo

备注/Memo:
基金项目:解放军总医院科技创新苗圃基金(16KMM43)
通信作者:陈莉丽,Email:13603612356@139.com
更新日期/Last Update: 2017-09-30